Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes. - Alhadj Ali M; Liu YF; Arif S; Tatovic D; Shariff H; Gibson VB; Yusuf N; Baptista R; Eichmann M; Petrov N; Heck S; Yang JHM; et al. (Science translational medicine, 2017)